KR:NYSEKroger Company (The) Analysis
Data as of 2026-06-07 - not real-time
$63.57
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The Kroger Co. (KR) is trading at $63.57, which sits below its 20‑day ($65.06), 50‑day ($67.44) and 200‑day ($66.76) simple moving averages, signaling short‑term weakness. RSI at 43.6 suggests the stock is not yet oversold, while the MACD histogram is negative and the signal line is bearish, reinforcing a neutral‑to‑downward bias. Volume is on an upward trend, indicating heightened trader interest amid recent news of aggressive price cuts and notable insider share sales that have pressured the price further. Investors are also watching the upcoming Q1 2026 earnings release, with consensus expectations of improved earnings per share, yet the market currently prices KR at a significant premium to its discounted cash‑flow fair value of $42.00, implying an overvaluation of roughly 18‑20%. The dividend yield of 2.2% remains attractive, but a payout ratio of 87% raises questions about long‑term sustainability despite solid free cash flow generation. Kroger’s low‑beta profile (≈0.4) and its defensive consumer‑staples positioning mitigate broader market swings, though the sector’s competitive pricing pressure and emerging ESG scrutiny add layers of risk. Overall, the stock reflects a blend of value concerns and growth potential, with the near‑term outlook clouded by pricing strategy execution and insider sentiment, while the medium‑term hinges on earnings momentum and the ability to translate cost‑cut initiatives into margin expansion.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Price below all major moving averages
- Bearish MACD and neutral RSI
- Recent insider selling and price‑cut news
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Upcoming earnings could unlock forward PE of 11.3
- Strong cash flow supporting dividend
- Competitive pricing pressure may improve margins
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Defensive consumer‑staples sector with low geographic risk
- Solid ROE and cash generation
- Potential price correction toward DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin0.69%
P/E Ratio41.3
ROE14.41%
ROA5.76%
Debt/Equity415.97
P/B Ratio6.9
Op. Cash Flow$7.3B
Free Cash Flow$3.4B
Technical Analysis
TrendNeutral
RSI43.6
Support$61.01
Resistance$71.71
MA 20$65.06
MA 50$67.44
MA 200$66.76
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Fair Value$42.01
Target Price$75.45
Upside/Downside18.70%
GradeOvervalued
TypeBlend
Dividend Yield2.20%
Risk Assessment
Beta-0.66
Volatility29.16%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.